Biomega (Norway) Overview

  • Founded
  • 2000
  • Status
  • Private
  • Employees
  • 41
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 4
  • Investments
  • 2

Biomega (Norway) General Information


Producer of salmon oil, salmon meal and hydrolyzed salmon proteins for the health and nutrition industry. The company's human-grade peptones, proteins and oils derived from fresh fish by-products are delivered as pet food ingredients, nutritional supplements and industrial bioactive components, enabling customers to use fresh raw materials.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Primary Office
  • Kong Christians
  • Frederiksplass 5
  • 5006 Bergen
  • Norway
+47 55 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomega (Norway) Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomega (Norway)‘s full profile, request access.

Request a free trial

Biomega (Norway) Patents

Biomega (Norway) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201807246-D0 Enzymatic method Ceased 02-May-2018 000000000
EP-3788160-A1 Enzymatic method Pending 02-May-2018 000000000

Biomega (Norway) Executive Team (12)

Name Title Board Seat Contact Info
Stig Peterson Chief Executive Officer
Espen Aarstad Chief Financial Officer
Jarl Knudsen Chief Operating Officer & Plant Manager
Andrew Dustan Ph.D Chief Technology Officer
Kjartan Sandnes Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Biomega (Norway) Board Members (6)

Name Representing Role Since
000000 00000 Self Board Member 000 0000
0000 000000 Biomega (Norway) Chairman 000 0000
You’re viewing 2 of 6 board members. Get the full list »

Biomega (Norway) Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biomega (Norway) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biomega (Norway)‘s full profile, request access.

Request a free trial

Biomega (Norway) Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000 02-Aug-2017 0000000000 Pharmaceuticals
Alkymar 10-Mar-2017 Buyout/LBO Other Commercial Services 000 0000 0000000
To view Biomega (Norway)’s complete investments history, request access »